ANI Pharmaceuticals, Inc. is a diversified bio-pharmaceutical company serving patients in need by developing, manufacturing, and marketing high quality branded and generic prescription pharmaceutical products.
ANI Pharmaceuticals Reports First Quarter 2022 Results; Provides Purified Cortrophin® Gel Net Revenue Guidance and Full-Year 2022 Total Company Net Revenue Guidance of $295 Million to $315 Million
ANI Pharmaceuticals to Discuss First Quarter 2022 Financial Results on May 10, 2022
+0.74 ( 2.536% )
Pricing delayed by 20 minutes
Last updated 05/19/2022 04:00 PM
What product are you looking for?